Loading…

Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin

Permanent human tumor cell lines are an important tool for the study of breast cancer. Two new breast cancer cell lines (BrCa‐MZ‐01 and BrCa‐MZ‐02) were isolated from a solid tumor and a pleural effusion, respectively. One cell line was established from a medullary carcinoma, the other from a ductal...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 1998-07, Vol.77 (3), p.415-423
Main Authors: Möbus, V. J., Moll, R., Gerharz, C. D., Kieback, D. G., Merk, O., Runnebaum, I. B., Linner, S., Dreher, L., Grill, H.‐J., Kreienberg, R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Permanent human tumor cell lines are an important tool for the study of breast cancer. Two new breast cancer cell lines (BrCa‐MZ‐01 and BrCa‐MZ‐02) were isolated from a solid tumor and a pleural effusion, respectively. One cell line was established from a medullary carcinoma, the other from a ductal carcinoma. These cells exhibit ultrastructural and immunohistochemical features of epithelial cells of mammary origin. Intermediate filament and cytokeratin typing showed a clear predominance of the simple‐epithelial cytokeratins CK 8, CK 18 and CK 19, although the expression was reduced in comparison to the hormone receptor‐positive reference cell lines MCF‐7 and ZR‐75‐1. Both cell lines produced slow‐growing tumors after subcutaneous (s.c.) transplantation of 1 × 107 viable tumor cells into nude mice. The cell line BrCa‐MZ‐01 expresses the estrogen and progesterone receptor, whereas the cell line BrCa‐MZ‐02 remains negative. Both cell lines are positive for secretion of platelet‐derived growth factor (PDGF) and transforming growth factor‐β (TGF‐β), whereas interleukin‐6 (IL‐6) is only secreted by the cell line BrCa‐MZ‐02. Int. J. Cancer 77:415–423, 1998. © 1998 Wiley‐Liss, Inc.
ISSN:0020-7136
1097-0215
DOI:10.1002/(SICI)1097-0215(19980729)77:3<415::AID-IJC18>3.0.CO;2-6